Phosphorylation of a 36,000 Mr cellular protein in cells infected with partial transformation mutants of rous sarcoma

Insights

Mutant Rous sarcoma viruses reveal that tyrosine phosphorylation of a 36,000 Mr protein is not essential for all cancer-like cell changes. However, this phosphorylation may be required for malignant growth properties.

Area of Science:

  • Virology
  • Molecular Biology
  • Oncology

Background:

  • Rous sarcoma virus (RSV) causes cell transformation through its pp60src protein.
  • Understanding the specific roles of pp60src targets is crucial for cancer research.

Purpose of the Study:

  • To investigate the role of tyrosine phosphorylation of a 36,000 Mr protein in Rous sarcoma virus-induced cell transformation.
  • To correlate this specific phosphorylation event with various transformation parameters.

Main Methods:

  • Isolation and characterization of Rous sarcoma virus mutants with altered pp60src activity.
  • Analysis of pp60src-mediated tyrosine phosphorylation of a 36,000 Mr protein in infected cells.
  • Correlation of phosphorylation levels with specific transformation phenotypes.

Main Results:

  • Phosphorylation of the 36,000 Mr protein was not necessary or sufficient for loss of fibronectin, loss of density-dependent growth inhibition, morphological changes, increased hexose transport, or loss of cell adhesion.
  • The strongest correlation observed was with increased plasminogen activator levels.
  • Mutant CU2, with low 36,000 Mr protein phosphorylation, showed deficiencies in anchorage-independent growth and tumorigenicity.

Conclusions:

  • Tyrosine phosphorylation of the 36,000 Mr protein is not a universal requirement for all RSV-induced transformation parameters.
  • This specific phosphorylation event may be essential for the acquisition of malignant growth properties, such as anchorage-independent growth and tumorigenicity.

Related Concept Videos

Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...